62 related articles for article (PubMed ID: 27311283)
1. [Physiological Function of Apolipoproteins and Atherosclerosis].
Seishima M
Rinsho Byori; 2016 Feb; 64(2):186-92. PubMed ID: 27311283
[TBL] [Abstract][Full Text] [Related]
2. Effect of plasma oncotic pressure on apolipoprotein levels in rats with Heymann nephritis.
Kaysen GA; Jones H; Joles JA; van Tol A
Miner Electrolyte Metab; 1996; 22(1-3):31-8. PubMed ID: 8676821
[TBL] [Abstract][Full Text] [Related]
3. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
[TBL] [Abstract][Full Text] [Related]
4. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
5. The effects of miR-467b on lipoprotein lipase (LPL) expression, pro-inflammatory cytokine, lipid levels and atherosclerotic lesions in apolipoprotein E knockout mice.
Tian GP; Tang YY; He PP; Lv YC; Ouyang XP; Zhao GJ; Tang SL; Wu JF; Wang JL; Peng J; Zhang M; Li Y; Cayabyab FS; Zheng XL; Zhang DW; Yin WD; Tang CK
Biochem Biophys Res Commun; 2014 Jan; 443(2):428-34. PubMed ID: 24309104
[TBL] [Abstract][Full Text] [Related]
6. Immune-regulation of the apolipoprotein A-I/C-III/A-IV gene cluster in experimental inflammation.
Navarro MA; Carpintero R; Acín S; Arbonés-Mainar JM; Calleja L; Carnicer R; Surra JC; Guzmán-García MA; González-Ramón N; Iturralde M; Lampreave F; Piñeiro A; Osada J
Cytokine; 2005 Jul; 31(1):52-63. PubMed ID: 15878672
[TBL] [Abstract][Full Text] [Related]
7. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
Zhou X; Paulsson G; Stemme S; Hansson GK
J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503
[TBL] [Abstract][Full Text] [Related]
8. Atherosclerosis and vascular disease: effects of peptide mimetics of apolipoproteins.
Garber DW; Handattu SP; Datta G; Mishra VK; Gupta H; White CR; Anantharamaiah GM
Curr Pharm Biotechnol; 2006 Aug; 7(4):235-40. PubMed ID: 16918400
[TBL] [Abstract][Full Text] [Related]
9. IL-1 beta and TNF-alpha suppress apolipoprotein (apo) E secretion and apo A-I expression in HepG2 cells.
Song H; Saito K; Fujigaki S; Noma A; Ishiguro H; Nagatsu T; Seishima M
Cytokine; 1998 Apr; 10(4):275-80. PubMed ID: 9617572
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
Maïga SF; Kalopissis AD; Chabert M
Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
[TBL] [Abstract][Full Text] [Related]
12. Combination of dietary phytosterols plus niacin or fenofibrate: effects on lipid profile and atherosclerosis in apo E-KO mice.
Yeganeh B; Moshtaghi-Kashanian GR; Declercq V; Moghadasian MH
J Nutr Biochem; 2005 Apr; 16(4):222-8. PubMed ID: 15808326
[TBL] [Abstract][Full Text] [Related]
13. [Intestinal apolipoprotein metabolism].
Steinmetz A
Klin Wochenschr; 1990; 68 Suppl 22():12-8. PubMed ID: 2087069
[TBL] [Abstract][Full Text] [Related]
14. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function.
Kahraman S; Kiykim AA; Altun B; Gençtoy G; Arici M; Gulsun M; Erdem Y; Yasavul U; Turgan C; Cağlar S
Clin Transplant; 2004 Jun; 18(3):288-94. PubMed ID: 15142050
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice.
Bhaskar V; Yin J; Mirza AM; Phan D; Vanegas S; Issafras H; Michelson K; Hunter JJ; Kantak SS
Atherosclerosis; 2011 Jun; 216(2):313-20. PubMed ID: 21411094
[TBL] [Abstract][Full Text] [Related]
17. Contribution of HDL-apolipoproteins to the inhibition of low density lipoprotein oxidation and lipid accumulation in macrophages.
Lin KY; Chen YL; Shih CC; Pan JP; Chan WE; Chiang AN
J Cell Biochem; 2002; 86(2):258-67. PubMed ID: 12111995
[TBL] [Abstract][Full Text] [Related]
18. [Apolipoprotein A I-C III-A IV deficiency].
Kato H
Nihon Rinsho; 1994 Dec; 52(12):3253-6. PubMed ID: 7853719
[TBL] [Abstract][Full Text] [Related]
19. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
[TBL] [Abstract][Full Text] [Related]
20. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
